Shattuck Labs (STTK) Asset Writedowns and Impairment (2022 - 2025)
Shattuck Labs' (STTK) quarterly Asset Writedowns and Impairment came in at $81000.0 in Q4 2025, up 8.0% year-on-year from $75000.0 in Q4 2024, and up 8.0% on a QoQ basis from $75000.0 in Q4 2024.
Shattuck Labs (STTK) Asset Writedowns and Impairment (2022 - 2025) Analysis & Trends
Shattuck Labs (STTK) has 4 years of Asset Writedowns and Impairment data on file, last reported at $81000.0 in Q4 2025.
- On a quarterly basis, Asset Writedowns and Impairment rose 8.0% year-over-year to $81000.0 in Q4 2025; TTM through Dec 2025 was $156000.0, a 58.73% decrease from a year earlier, with the FY2025 full-year figure at $81000.0, down 63.51% from the prior year.
- Asset Writedowns and Impairment for Q4 2025 stood at $81000.0, up from $75000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for STTK reached as high as $400000.0 in Q2 2022 and fell as low as $75000.0 in Q4 2024.
- Historically, Asset Writedowns and Impairment has averaged $209833.3 across 4 years, with a median of $151500.0 in 2023.
- Across the five-year window, Asset Writedowns and Impairment plunged 49.0% in 2023 and grew 8.0% in 2025, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $400000.0 in 2022, then sank by 75.25% to $99000.0 in 2023, then dropped by 24.24% to $75000.0 in 2024, then grew by 8.0% to $81000.0 in 2025.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $81000.0 in Q4 2025, $75000.0 in Q4 2024, and $99000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 81,000.00 |
| Dec 31, 2025 | 81,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Sep 30, 2023 | 204,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 400,000.00 |